2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidine...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 239/34 (2006.01) A61K 31/505 (2006.01) A61K 31/53 (2006.01) C07D 263/32 (2006.01) C07D 401/02 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 403/02 (2006.01) C07D 403/06 (2006.01) C07D 405/02 (2006.01) C07D 409/02 (2006.01) C07D 413/02 (2006.01) C07D 413/06 (2006.01) C07D 417/02 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2099867

The present invention is novel compounds having the following general formula: Image which are 2-substituted-4,6-di-tertiarybutyl-5-hydroxy- 1,3-pyrimidines and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and methods of use therefor. The invention compounds are now found to have activity as inhibitors of 5-lipoxygenase and/or cyclooxygenase providing treatment of conditions advantageously affected by such inhibition including inflammation, arthritis, pain, fever and the like. Thus, the present invention is also a pharmaceutical composition or method of manufacturing a pharmaceutical composition for the use of treating the noted conditions.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidine... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1588214

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.